You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
7 July 2015
Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow
Oasmia Pharmaceutical Launches US Brand and Sales Platform
29 May 2015
Changes in Oasmia’s Board of Directors and Management
7 May 2015
Oasmia gives notice of Extraordinary General Meeting
24 April 2015
Results from Oasmia’s Phase III study will be presented at ASCO
20 April 2015
Oasmia’s lead cancer product Paclical(r) receives market approval in the Russian Federation